Logo image of FEMY

FEMASYS INC (FEMY) Stock Fundamental Analysis

USA - Nasdaq - NASDAQ:FEMY - US31447E1055 - Common Stock

0.728 USD
-0.07 (-9%)
Last: 12/24/2025, 7:28:46 PM
0.725 USD
0 (-0.41%)
After Hours: 12/24/2025, 7:28:46 PM
Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to FEMY. FEMY was compared to 185 industry peers in the Health Care Equipment & Supplies industry. Both the profitability and financial health of FEMY have multiple concerns. FEMY is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year FEMY has reported negative net income.
In the past year FEMY has reported a negative cash flow from operations.
FEMY had negative earnings in each of the past 5 years.
In the past 5 years FEMY always reported negative operating cash flow.
FEMY Yearly Net Income VS EBIT VS OCF VS FCFFEMY Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 -5M -10M -15M -20M

1.2 Ratios

The Return On Assets of FEMY (-152.51%) is worse than 88.11% of its industry peers.
The Return On Equity of FEMY (-1394.22%) is worse than 85.95% of its industry peers.
Industry RankSector Rank
ROA -152.51%
ROE -1394.22%
ROIC N/A
ROA(3y)-89.97%
ROA(5y)-77.42%
ROE(3y)-322.97%
ROE(5y)-238.66%
ROIC(3y)N/A
ROIC(5y)N/A
FEMY Yearly ROA, ROE, ROICFEMY Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 -200 -400 -600 -800

1.3 Margins

Looking at the Gross Margin, with a value of 65.09%, FEMY is in the better half of the industry, outperforming 68.11% of the companies in the same industry.
FEMY's Gross Margin has declined in the last couple of years.
FEMY does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 65.09%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.03%
GM growth 5Y-2.71%
FEMY Yearly Profit, Operating, Gross MarginsFEMY Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 0 -500 -1K

More info and screens

0

2. Health

2.1 Basic Checks

FEMY does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, FEMY has more shares outstanding
Compared to 5 years ago, FEMY has more shares outstanding
FEMY has a worse debt/assets ratio than last year.
FEMY Yearly Shares OutstandingFEMY Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M
FEMY Yearly Total Debt VS Total AssetsFEMY Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M

2.2 Solvency

Based on the Altman-Z score of -16.28, we must say that FEMY is in the distress zone and has some risk of bankruptcy.
FEMY has a worse Altman-Z score (-16.28) than 87.03% of its industry peers.
FEMY has a Debt/Equity ratio of 4.03. This is a high value indicating a heavy dependency on external financing.
FEMY's Debt to Equity ratio of 4.03 is on the low side compared to the rest of the industry. FEMY is outperformed by 84.32% of its industry peers.
Industry RankSector Rank
Debt/Equity 4.03
Debt/FCF N/A
Altman-Z -16.28
ROIC/WACCN/A
WACC8.08%
FEMY Yearly LT Debt VS Equity VS FCFFEMY Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 10M -10M 20M -20M

2.3 Liquidity

A Current Ratio of 0.89 indicates that FEMY may have some problems paying its short term obligations.
FEMY has a Current ratio of 0.89. This is amonst the worse of the industry: FEMY underperforms 89.19% of its industry peers.
FEMY has a Quick Ratio of 0.89. This is a bad value and indicates that FEMY is not financially healthy enough and could expect problems in meeting its short term obligations.
The Quick ratio of FEMY (0.41) is worse than 93.51% of its industry peers.
Industry RankSector Rank
Current Ratio 0.89
Quick Ratio 0.41
FEMY Yearly Current Assets VS Current LiabilitesFEMY Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M

More info and screens

6

3. Growth

3.1 Past

The Earnings Per Share has grown by an nice 12.35% over the past year.
Looking at the last year, FEMY shows a very strong growth in Revenue. The Revenue has grown by 51.97%.
FEMY shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 11.86% yearly.
EPS 1Y (TTM)12.35%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%58.33%
Revenue 1Y (TTM)51.97%
Revenue growth 3Y11.35%
Revenue growth 5Y11.86%
Sales Q2Q%31.35%

3.2 Future

Based on estimates for the next years, FEMY will show a quite strong growth in Earnings Per Share. The EPS will grow by 15.28% on average per year.
Based on estimates for the next years, FEMY will show a very strong growth in Revenue. The Revenue will grow by 97.39% on average per year.
EPS Next Y33.6%
EPS Next 2Y24.9%
EPS Next 3Y18.64%
EPS Next 5Y15.28%
Revenue Next Year-2.37%
Revenue Next 2Y55.35%
Revenue Next 3Y100.14%
Revenue Next 5Y97.39%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
FEMY Yearly Revenue VS EstimatesFEMY Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 50M 100M 150M 200M 250M
FEMY Yearly EPS VS EstimatesFEMY Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 0 1 -1 2

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for FEMY. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for FEMY. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
FEMY Price Earnings VS Forward Price EarningsFEMY Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30 40

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
FEMY Per share dataFEMY EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -0.2 -0.4 -0.6

4.3 Compensation for Growth

FEMY's earnings are expected to grow with 18.64% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y24.9%
EPS Next 3Y18.64%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for FEMY!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

FEMASYS INC

NASDAQ:FEMY (12/24/2025, 7:28:46 PM)

After market: 0.725 0 (-0.41%)

0.728

-0.07 (-9%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)11-14 2025-11-14/amc
Earnings (Next)03-25 2026-03-25/amc
Inst Owners8.1%
Inst Owner Change-26.05%
Ins Owners8.23%
Ins Owner Change4.48%
Market Cap42.57M
Revenue(TTM)1.63M
Net Income(TTM)-21.02M
Analysts82.22
Price TargetN/A
Short Float %3.65%
Short Ratio0.21
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-0.19%
Min EPS beat(2)-18.68%
Max EPS beat(2)18.3%
EPS beat(4)1
Avg EPS beat(4)-9.98%
Min EPS beat(4)-21.89%
Max EPS beat(4)18.3%
EPS beat(8)3
Avg EPS beat(8)-5.92%
EPS beat(12)5
Avg EPS beat(12)-4.03%
EPS beat(16)7
Avg EPS beat(16)-0.14%
Revenue beat(2)0
Avg Revenue beat(2)-62.91%
Min Revenue beat(2)-70.71%
Max Revenue beat(2)-55.12%
Revenue beat(4)0
Avg Revenue beat(4)-51.94%
Min Revenue beat(4)-70.71%
Max Revenue beat(4)-16.58%
Revenue beat(8)0
Avg Revenue beat(8)-46.57%
Revenue beat(12)1
Avg Revenue beat(12)-34.57%
Revenue beat(16)3
Avg Revenue beat(16)-25.25%
PT rev (1m)-17.33%
PT rev (3m)-17.33%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-4%
EPS NY rev (1m)6.22%
EPS NY rev (3m)6.22%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)8.75%
Revenue NY rev (1m)-9.7%
Revenue NY rev (3m)-19.42%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 22.56
P/FCF N/A
P/OCF N/A
P/B 28.24
P/tB 29.32
EV/EBITDA N/A
EPS(TTM)-0.71
EYN/A
EPS(NY)-0.37
Fwd EYN/A
FCF(TTM)-0.35
FCFYN/A
OCF(TTM)-0.34
OCFYN/A
SpS0.03
BVpS0.03
TBVpS0.02
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -152.51%
ROE -1394.22%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 65.09%
FCFM N/A
ROA(3y)-89.97%
ROA(5y)-77.42%
ROE(3y)-322.97%
ROE(5y)-238.66%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.03%
GM growth 5Y-2.71%
F-Score3
Asset Turnover0.14
Health
Industry RankSector Rank
Debt/Equity 4.03
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 222.91%
Cap/Sales 39.29%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.89
Quick Ratio 0.41
Altman-Z -16.28
F-Score3
WACC8.08%
ROIC/WACCN/A
Cap/Depr(3y)129.38%
Cap/Depr(5y)89.02%
Cap/Sales(3y)33.12%
Cap/Sales(5y)25.7%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)12.35%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%58.33%
EPS Next Y33.6%
EPS Next 2Y24.9%
EPS Next 3Y18.64%
EPS Next 5Y15.28%
Revenue 1Y (TTM)51.97%
Revenue growth 3Y11.35%
Revenue growth 5Y11.86%
Sales Q2Q%31.35%
Revenue Next Year-2.37%
Revenue Next 2Y55.35%
Revenue Next 3Y100.14%
Revenue Next 5Y97.39%
EBIT growth 1Y-16.28%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-82.75%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-79%
OCF growth 3YN/A
OCF growth 5YN/A

FEMASYS INC / FEMY FAQ

What is the ChartMill fundamental rating of FEMASYS INC (FEMY) stock?

ChartMill assigns a fundamental rating of 2 / 10 to FEMY.


Can you provide the valuation status for FEMASYS INC?

ChartMill assigns a valuation rating of 0 / 10 to FEMASYS INC (FEMY). This can be considered as Overvalued.


Can you provide the profitability details for FEMASYS INC?

FEMASYS INC (FEMY) has a profitability rating of 1 / 10.


How financially healthy is FEMASYS INC?

The financial health rating of FEMASYS INC (FEMY) is 0 / 10.


What is the earnings growth outlook for FEMASYS INC?

The Earnings per Share (EPS) of FEMASYS INC (FEMY) is expected to grow by 33.6% in the next year.